Indication

Drowsy

Drowsiness, also medically termed somnolence, is a state of abnormal daytime sleepiness characterized by difficulty maintaining alertness and an unintended urge or propensity to fall asleep. Read more about Drowsy

27 drugs 22 manufacturers

Advertisement

Drugs that treat it

Common Drowsy therapies.

Showing 1–9 of 27 drugs

CAFFEINE

AMPHETAMINES/ANOREXIANTS/STIMULANTS·DROWSY·+1
CVS

CAFFEINE

AMPHETAMINES/ANOREXIANTS/STIMULANTS·DROWSY·+1
GSK Consumer Healthcare
Filter & compare in the drug finder →Opens the drug finder with Drowsy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Drowsy.

Drowsiness, also medically termed somnolence, is a state of abnormal daytime sleepiness characterized by difficulty maintaining alertness and an unintended urge or propensity to fall asleep.

Mediated by the central nervous system—specifically disruptions in the neurochemical circuitry governing sleep-wake homeostasis, ascending reticular activating system signaling, and orexinergic tone—it can affect individuals of any age group.

Clinically, it manifests as sluggish cognition, yawning, impaired psychomotor performance, and recurrent involuntary lapses into sleep during waking hours.

It often arises secondary to chronic sleep deprivation, primary sleep disorders such as obstructive sleep apnea and narcolepsy, metabolic derangements, or central nervous system depressant medications.

Personalize your experience

Follow Drowsy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it